SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Frederick Law Olmsted Synthetic CCD

PatientFrederick Law Olmsted
Date of birth1953-04-26
IdentifiersMRN HR-NI022-SYN; SSN (made up) 000-22-5519
Document date2026-11-01
AuthorNathan Calder, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Cognitive evaluation for progressive memory loss: history from patient and caregiver, MoCA, function, mood, safety, and reversible-cause tests. Concerns: He is frustrated that he can no longer keep the details of his projects in mind and wants to understand what is happening; His caregiver wants to keep him safe at home and needs help and information. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Donepezil 5 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morning with breakfastOral route2026-06-02 to 2026-08-04completedS
Donepezil 10 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morning with breakfastOral route2026-08-04activeS

Procedures

ProcedureDatesStatusEvidence
MRI of the brain without contrast: generalized cortical atrophy beyond that expected for age, with mild bilateral medial temporal atrophy (MTA score 2) and scattered small white-matter hyperintensities (Fazekas grade 1); no infarct, hemorrhage, mass, or hydrocephalus2026-05-19 to 2026-05-19completedS
Advance care planning conversation with the patient and his caregiver, about 30 minutes2026-08-04 to 2026-08-04completedS

Immunizations

DateVaccineStatusEvidence
2025-10-21High-dose influenza vaccine, 2025-2026 seasoncompletedS
2026-09-15High-dose influenza vaccine, 2026-2027 seasoncompletedS
2026-09-15Pneumococcal conjugate vaccine PCV20completedS
2026-09-15Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1863Exhaustion and illness from overwork while leading a national wartime relief commission, ending in his resignation in 1863; illness not specified in the cited sourceD (CLM-0009)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He is frustrated that he can no longer keep the details of his projects in mind and wants to understand what is happeningactiveS
His caregiver wants to keep him safe at home and needs help and informationactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 14.1 on 2026-05-05; Leukocytes [#/volume] in Blood by Automated count 6.2 on 2026-05-05; Platelets [#/volume] in Blood by Automated count 238 on 2026-05-05; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-05-05; Potassium [Moles/volume] in Serum or Plasma 4.3 on 2026-05-05; Creatinine [Mass/volume] in Serum or Plasma 1.02 on 2026-05-05; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 76 on 2026-05-05; Glucose [Mass/volume] in Serum or Plasma 94 on 2026-05-05; Calcium [Mass/volume] in Serum or Plasma 9.4 on 2026-05-05; Albumin [Mass/volume] in Serum or Plasma 4.1 on 2026-05-05; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 2026-05-05; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 410 on 2026-05-05; Folate [Mass/volume] in Serum or Plasma 12.4 on 2026-05-05; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 2026-05-05; Total score [MoCA] 19 on 2026-05-05; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 2026-10-27; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 2026-09-15; Total score [AUDIT-C] 0 on 2026-09-15; Cholesterol [Mass/volume] in Serum or Plasma 196 on 2026-09-15; Cholesterol in HDL [Mass/volume] in Serum or Plasma 54 on 2026-09-15; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 118 on 2026-09-15; Triglyceride [Mass/volume] in Serum or Plasma 120 on 2026-09-15 [S]

Strengths and supports: Supports: his primary caregiver, family at home, long-time colleagues who visit, and a lifelong love of gardens and walking [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Mild dementia (major neurocognitive disorder), progressive, amnestic-predominant with executive difficulty, type undetermined; CDR global 1activeconfirmed F03.A0S — Synthetic modern coding of his documented failing memory; the cause is unknown, so the type is left unspecified. Stage and scores are synthetic.
Common cold, with two nights of increased confusion after an over-the-counter nighttime cold medicine containing diphenhydramine; resolvedresolvedconfirmed J00S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.
Progressive memory loss over about two years with decline in managing his work and affairs, under evaluation for dementia or mild cognitive impairmentresolvedconfirmed R41.3S — Synthetic presenting concern at the index visit, superseded by the dementia diagnosis at the four-week visit; the failing memory is documented (D).

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-05Hemoglobin [Mass/volume] in Blood14.1g/dL13.2-16.6 g/dLNormalS
2026-05-05Leukocytes [#/volume] in Blood by Automated count6.210*3/uL3.4-9.6 10*3/uLNormalS
2026-05-05Platelets [#/volume] in Blood by Automated count23810*3/uL135-317 10*3/uLNormalS
2026-05-05Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-05-05Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-05-05Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-05-05Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M76mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-05-05Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-05-05Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
2026-05-05Albumin [Mass/volume] in Serum or Plasma4.1g/dL3.5-5 g/dLNormalS
2026-05-05Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-55 U/LNormalS
2026-05-05Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma410pg/mL232-1245 pg/mLNormalS
2026-05-05Folate [Mass/volume] in Serum or Plasma12.4ng/mL>=5.9 ng/mLNormalS
2026-05-05Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.45-4.5 mIU/LNormalS
2026-05-05Total score [MoCA]19{score}S
2026-05-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-09-15Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-09-15Total score [AUDIT-C]0{score}S
2026-09-15Cholesterol [Mass/volume] in Serum or Plasma196mg/dL<=200 mg/dLNormalS
2026-09-15Cholesterol in HDL [Mass/volume] in Serum or Plasma54mg/dL>=40 mg/dLNormalS
2026-09-15Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation118mg/dL<=129 mg/dLNormalS
2026-09-15Triglyceride [Mass/volume] in Serum or Plasma120mg/dL<=149 mg/dLNormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-05-05Body height175cmS
2026-05-05Body weight72kgS
2026-05-05Body mass index (BMI) [Ratio]23.5kg/m2S
2026-05-05Systolic blood pressure134mm[Hg]S
2026-05-05Diastolic blood pressure78mm[Hg]S
2026-05-05Heart rate72/minS
2026-05-05Respiratory rate14/minS
2026-05-05Body temperature36.7CelS
2026-05-05Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-06-02Body height175cmS
2026-06-02Body weight71.8kgS
2026-06-02Body mass index (BMI) [Ratio]23.4kg/m2S
2026-06-02Systolic blood pressure132mm[Hg]S
2026-06-02Diastolic blood pressure76mm[Hg]S
2026-06-02Heart rate70/minS
2026-06-02Respiratory rate14/minS
2026-06-02Body temperature36.6CelS
2026-06-02Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-08-04Body height175cmS
2026-08-04Body weight71.2kgS
2026-08-04Body mass index (BMI) [Ratio]23.2kg/m2S
2026-08-04Systolic blood pressure128mm[Hg]S
2026-08-04Diastolic blood pressure76mm[Hg]S
2026-08-04Heart rate62/minS
2026-08-04Respiratory rate14/minS
2026-08-04Body temperature36.6CelS
2026-08-04Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-10-27Body height175cmS
2026-10-27Body weight71kgS
2026-10-27Body mass index (BMI) [Ratio]23.2kg/m2S
2026-10-27Systolic blood pressure130mm[Hg]S
2026-10-27Diastolic blood pressure76mm[Hg]S
2026-10-27Heart rate60/minS
2026-10-27Respiratory rate14/minS
2026-10-27Body temperature36.6CelS
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-07-14Body height175cmS
2026-07-14Body weight71.4kgS
2026-07-14Body mass index (BMI) [Ratio]23.3kg/m2S
2026-07-14Systolic blood pressure130mm[Hg]S
2026-07-14Diastolic blood pressure74mm[Hg]S
2026-07-14Heart rate70/minS
2026-07-14Respiratory rate16/minS
2026-07-14Body temperature37.4CelS
2026-07-14Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-09-15Body height175cmS
2026-09-15Body weight71kgS
2026-09-15Body mass index (BMI) [Ratio]23.2kg/m2S
2026-09-15Systolic blood pressure128mm[Hg]S
2026-09-15Diastolic blood pressure74mm[Hg]S
2026-09-15Heart rate60/minS
2026-09-15Respiratory rate14/minS
2026-09-15Body temperature36.6CelS
2026-09-15Oxygen saturation in Arterial blood by Pulse oximetry97%S

Encounters

DatePurposeStatusProvenance
2026-05-05Cognitive evaluation for progressive memory loss: history from patient and caregiver, MoCA, function, mood, safety, and reversible-cause testsfinishedS
2026-06-02Four-week follow-up: results and MRI review, diagnosis disclosure, and behavioral neurology consultationfinishedS
2026-08-04Three-month dementia review: donepezil, safety plan, caregiver burden, and advance care planningfinishedS
2026-10-27Six-month dementia reviewfinishedS
2026-07-14Same-day sick visit for a head cold with night-time confusionfinishedS
2026-09-15Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Reversible-cause tests (blood count, metabolic panel, vitamin B12, folate, TSH) and one non-contrast brain MRI; syphilis and HIV testing only with risk factors or atypical featurescompletedGL-AAN-DEM-2001, GL-ALZ-PC-2025, GL-CMID-2026S
Behavioral neurology consultation to confirm the diagnosis, consider the type and biomarker testing, and advise on treatment and drivingcompletedGL-ALZ-SC-2025, GL-AAN-DEM-2001, GL-AAN-DRIVE-2010S
Donepezil trial, 5 mg daily for four to eight weeks then 10 mg, with heart rate, fainting, gastrointestinal effects, weight, and sleep checked at each visit; avoid anticholinergic drugs, first-generation antihistamines, benzodiazepines, and sleeping pills (AGS Beers Criteria)completedGL-CMID-2026, GL-BEERS-2023S
Safety: stop driving at CDR 1, keep the home free of firearms, medical identification for wandering, supervised medicines and finances, and home safetycompletedGL-AAN-DRIVE-2010, GL-CMID-2026S
Caregiver support: Zarit Burden Interview at diagnosis and every six to twelve months, education, adult day program and respite, and Alzheimer's Association support servicescompletedGL-CMID-2026, GL-ALZ-PC-2025S
Monitor on the CMID dementia schedule: medication review and neuropsychiatric screen at every visit; MoCA, ADL and IADL, CDR or FAST stage, depression screen, fall risk, driving, and advance care planning yearly; repeat tests or imaging only with a sudden changecompletedGL-CMID-2026S
Advance care planning while he can take part: name a health care agent and record his values and wishescompletedGL-CMID-2026, GL-ALZ-PC-2025S

Goals

GoalTargetStatusOutcomeProvenance
Complete the reversible-cause tests and brain MRI and discuss the diagnosis with him and his caregiver by the four-week visit2026-06-02completedTests and MRI showed no reversible cause; diagnosis of mild dementia of undetermined type discussed with bothS
A safety plan in place by the three-month review: no driving, medicines supervised, finances overseen, and medical identification worn2026-08-04completedStopped driving after the consultation; caregiver gives medicines from a weekly organizer and oversees bill paying with his agreement; medical identification bracelet wornS
Donepezil at 10 mg daily without side effects and with resting heart rate 55 or above by the six-month review2026-10-27completedOn 10 mg for three months; heart rate 60; no nausea, diarrhea, weight loss, or vivid dreamsS
Caregiver burden assessed and support in place by the six-month review2026-10-27completedZarit Burden Interview 24 at three months; caregiver education program completed and two days a week of adult day program begunS
Name a health care agent and record his values and wishes while he can take full part, by the three-month review2026-08-04completedHealth care agent named and his wishes recorded at the three-month reviewS

Functional Status

Mental Status